Considerations on antimicrobial prophylaxis in patients with lymphoproliferative diseases: A SEIFEM group position paper

Alessandro Busca; Chiara Cattaneo; Elena De Carolis; Gianpaolo Nadali; Massimo Offidani; Marco Picardi; Anna Candoni; Eleonora Ceresoli; Marianna Criscuolo; Mario Delia; Roberta Della Pepa; Ilaria Del Principe; Roma Rosa Fanci; Francesca Farina; Nicola Fracchiolla; Claudia Giordano; Michele Malagola; Francesco Marchesi; Monica Piedimonte; Lucia Prezioso; Angela Maria Quinto; Angelica Spolzino; Maria Chiara Tisi; Fabio Trastulli; Enrico Maria Trecarichi; Patrizia Zappasodi; Mario Tumbarello; Livio Pagano

doi:10.1016/j.critrevonc.2020.103203

Considerations on antimicrobial prophylaxis in patients with lymphoproliferative diseases: A SEIFEM group position paper

Alessandro Busca, Chiara Cattaneo, Elena De Carolis, Gianpaolo Nadali, Massimo Offidani, Marco Picardi, Anna Candoni, Eleonora Ceresoli, Marianna Criscuolo, Mario Delia, Roberta Della Pepa, Ilaria Del Principe, Roma Rosa Fanci, Francesca Farina, Nicola Fracchiolla, Claudia Giordano, Michele Malagola, Francesco Marchesi, Monica Piedimonte, Lucia PreziosoAngela Maria Quinto, Angelica Spolzino, Maria Chiara Tisi, Fabio Trastulli, Enrico Maria Trecarichi, Patrizia Zappasodi, Mario Tumbarello, Livio Pagano

Research output: Contribution to journal › Review article › peer-review

Abstract

The therapeutic armamentarium for the treatment of patients with lymphoproliferative diseases has grown considerably over the most recent years, including a large use of new immunotherapeutic agents. As a consequence, the epidemiology of infectious complications in this group of patients is poorly documented, and even more importantly, the potential benefit of antimicrobial prophylaxis remains a matter of debate when considering the harmful effect from the emergence of multidrug resistant pathogens. The present position paper is addressed to all hematologists treating patients affected by lymphoproliferative malignancies with the aim to provide clinicians with a useful tool for the prevention of bacterial, fungal and viral infections.

Original language	English
Article number	103203
Journal	Critical Reviews in Oncology/Hematology
Volume	158
DOIs	https://doi.org/10.1016/j.critrevonc.2020.103203
Publication status	Published - Feb 2021

Keywords

Antimicrobial prophylaxis
Antimicrobial stewardship.
Bacterial
Fungal and viral infections
Lymphoproliferative disorders

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1016/j.critrevonc.2020.103203

Fingerprint Dive into the research topics of 'Considerations on antimicrobial prophylaxis in patients with lymphoproliferative diseases: A SEIFEM group position paper'. Together they form a unique fingerprint.

Cite this

Busca, A., Cattaneo, C., De Carolis, E., Nadali, G., Offidani, M., Picardi, M., Candoni, A., Ceresoli, E., Criscuolo, M., Delia, M., Della Pepa, R., Del Principe, I., Fanci, R. R., Farina, F., Fracchiolla, N., Giordano, C., Malagola, M., Marchesi, F., Piedimonte, M., ... Pagano, L. (2021). Considerations on antimicrobial prophylaxis in patients with lymphoproliferative diseases: A SEIFEM group position paper. Critical Reviews in Oncology/Hematology, 158, [103203]. https://doi.org/10.1016/j.critrevonc.2020.103203

Considerations on antimicrobial prophylaxis in patients with lymphoproliferative diseases : A SEIFEM group position paper. / Busca, Alessandro; Cattaneo, Chiara; De Carolis, Elena; Nadali, Gianpaolo; Offidani, Massimo; Picardi, Marco; Candoni, Anna; Ceresoli, Eleonora; Criscuolo, Marianna; Delia, Mario; Della Pepa, Roberta; Del Principe, Ilaria; Fanci, Roma Rosa; Farina, Francesca ; Fracchiolla, Nicola; Giordano, Claudia; Malagola, Michele; Marchesi, Francesco; Piedimonte, Monica; Prezioso, Lucia; Quinto, Angela Maria; Spolzino, Angelica; Tisi, Maria Chiara; Trastulli, Fabio; Trecarichi, Enrico Maria; Zappasodi, Patrizia ; Tumbarello, Mario ; Pagano, Livio.

In: Critical Reviews in Oncology/Hematology, Vol. 158, 103203, 02.2021.

Research output: Contribution to journal › Review article › peer-review

Busca, A, Cattaneo, C, De Carolis, E, Nadali, G, Offidani, M, Picardi, M, Candoni, A, Ceresoli, E, Criscuolo, M, Delia, M, Della Pepa, R, Del Principe, I, Fanci, RR, Farina, F , Fracchiolla, N, Giordano, C, Malagola, M, Marchesi, F, Piedimonte, M, Prezioso, L, Quinto, AM, Spolzino, A, Tisi, MC, Trastulli, F, Trecarichi, EM, Zappasodi, P , Tumbarello, M & Pagano, L 2021, 'Considerations on antimicrobial prophylaxis in patients with lymphoproliferative diseases: A SEIFEM group position paper', Critical Reviews in Oncology/Hematology, vol. 158, 103203. https://doi.org/10.1016/j.critrevonc.2020.103203

Busca, Alessandro ; Cattaneo, Chiara ; De Carolis, Elena ; Nadali, Gianpaolo ; Offidani, Massimo ; Picardi, Marco ; Candoni, Anna ; Ceresoli, Eleonora ; Criscuolo, Marianna ; Delia, Mario ; Della Pepa, Roberta ; Del Principe, Ilaria ; Fanci, Roma Rosa ; Farina, Francesca ; Fracchiolla, Nicola ; Giordano, Claudia ; Malagola, Michele ; Marchesi, Francesco ; Piedimonte, Monica ; Prezioso, Lucia ; Quinto, Angela Maria ; Spolzino, Angelica ; Tisi, Maria Chiara ; Trastulli, Fabio ; Trecarichi, Enrico Maria ; Zappasodi, Patrizia ; Tumbarello, Mario ; Pagano, Livio. / Considerations on antimicrobial prophylaxis in patients with lymphoproliferative diseases : A SEIFEM group position paper. In: Critical Reviews in Oncology/Hematology. 2021 ; Vol. 158.

@article{1026a592a4274450b49838a0e508daec,

title = "Considerations on antimicrobial prophylaxis in patients with lymphoproliferative diseases: A SEIFEM group position paper",

abstract = "The therapeutic armamentarium for the treatment of patients with lymphoproliferative diseases has grown considerably over the most recent years, including a large use of new immunotherapeutic agents. As a consequence, the epidemiology of infectious complications in this group of patients is poorly documented, and even more importantly, the potential benefit of antimicrobial prophylaxis remains a matter of debate when considering the harmful effect from the emergence of multidrug resistant pathogens. The present position paper is addressed to all hematologists treating patients affected by lymphoproliferative malignancies with the aim to provide clinicians with a useful tool for the prevention of bacterial, fungal and viral infections.",

keywords = "Antimicrobial prophylaxis, Antimicrobial stewardship., Bacterial, Fungal and viral infections, Lymphoproliferative disorders",

author = "Alessandro Busca and Chiara Cattaneo and {De Carolis}, Elena and Gianpaolo Nadali and Massimo Offidani and Marco Picardi and Anna Candoni and Eleonora Ceresoli and Marianna Criscuolo and Mario Delia and {Della Pepa}, Roberta and {Del Principe}, Ilaria and Fanci, {Roma Rosa} and Francesca Farina and Nicola Fracchiolla and Claudia Giordano and Michele Malagola and Francesco Marchesi and Monica Piedimonte and Lucia Prezioso and Quinto, {Angela Maria} and Angelica Spolzino and Tisi, {Maria Chiara} and Fabio Trastulli and Trecarichi, {Enrico Maria} and Patrizia Zappasodi and Mario Tumbarello and Livio Pagano",

year = "2021",

month = feb,

doi = "10.1016/j.critrevonc.2020.103203",

language = "English",

volume = "158",

journal = "Critical Reviews in Oncology/Hematology",

issn = "1040-8428",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Considerations on antimicrobial prophylaxis in patients with lymphoproliferative diseases

T2 - A SEIFEM group position paper

AU - Busca, Alessandro

AU - Cattaneo, Chiara

AU - De Carolis, Elena

AU - Nadali, Gianpaolo

AU - Offidani, Massimo

AU - Picardi, Marco

AU - Candoni, Anna

AU - Ceresoli, Eleonora

AU - Criscuolo, Marianna

AU - Delia, Mario

AU - Della Pepa, Roberta

AU - Del Principe, Ilaria

AU - Fanci, Roma Rosa

AU - Farina, Francesca

AU - Fracchiolla, Nicola

AU - Giordano, Claudia

AU - Malagola, Michele

AU - Marchesi, Francesco

AU - Piedimonte, Monica

AU - Prezioso, Lucia

AU - Quinto, Angela Maria

AU - Spolzino, Angelica

AU - Tisi, Maria Chiara

AU - Trastulli, Fabio

AU - Trecarichi, Enrico Maria

AU - Zappasodi, Patrizia

AU - Tumbarello, Mario

AU - Pagano, Livio

PY - 2021/2

Y1 - 2021/2

N2 - The therapeutic armamentarium for the treatment of patients with lymphoproliferative diseases has grown considerably over the most recent years, including a large use of new immunotherapeutic agents. As a consequence, the epidemiology of infectious complications in this group of patients is poorly documented, and even more importantly, the potential benefit of antimicrobial prophylaxis remains a matter of debate when considering the harmful effect from the emergence of multidrug resistant pathogens. The present position paper is addressed to all hematologists treating patients affected by lymphoproliferative malignancies with the aim to provide clinicians with a useful tool for the prevention of bacterial, fungal and viral infections.

AB - The therapeutic armamentarium for the treatment of patients with lymphoproliferative diseases has grown considerably over the most recent years, including a large use of new immunotherapeutic agents. As a consequence, the epidemiology of infectious complications in this group of patients is poorly documented, and even more importantly, the potential benefit of antimicrobial prophylaxis remains a matter of debate when considering the harmful effect from the emergence of multidrug resistant pathogens. The present position paper is addressed to all hematologists treating patients affected by lymphoproliferative malignancies with the aim to provide clinicians with a useful tool for the prevention of bacterial, fungal and viral infections.

KW - Antimicrobial prophylaxis

KW - Antimicrobial stewardship.

KW - Bacterial

KW - Fungal and viral infections

KW - Lymphoproliferative disorders

UR - http://www.scopus.com/inward/record.url?scp=85099252160&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85099252160&partnerID=8YFLogxK

U2 - 10.1016/j.critrevonc.2020.103203

DO - 10.1016/j.critrevonc.2020.103203

M3 - Review article

AN - SCOPUS:85099252160

VL - 158

JO - Critical Reviews in Oncology/Hematology

JF - Critical Reviews in Oncology/Hematology

SN - 1040-8428

M1 - 103203

ER -